SITC Cancer Immunotherapy CONNECT

sitc_log_color.png

Apply Today for the 2019
SITC Fellowships

Young investigators have until Feb. 25 to apply any of three, $100,000 Fellowship Awards

LEARN MORE

sitc_log_color.png

Women in Cancer Immunotherapy Network Leadership Institute

Seattle on Aug. 19–20, 2019
Empowering women in the cancer immunotherapy field

Apply by April 15 to attend this free program.

LEARN MORE

aci17-cmyk.png
Are you up to date with I-O?
Attend an upcoming SITC Advances in Cancer Immunotherapy™ Program


Portland, Ore. | Denver | Salt Lake City
Toronto | New Orleans

 



Small_Hwu_Carousel.jpg

Why I'm a SITC Member

Join Leisha A. Emens, MD, PhD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.

Become a SITC Member




Winter_School.png


Attend SITC's Comprehensive Cancer Immunotherapy Advanced Training Program Feb. 18–22, 2019

LEARN MORE


 

Now Available:
SITC 2018 Enduring Materials

ACCESS OR PURCHASE Slides and Videos TODAY

sitc_log_color.png

SITC-ONS Joint Session at ONS Congress
SITC and Oncology Nursing Society will host a joint session, Checks & Balances: Cancer Immunotherapy for the Advanced Practice Nurse, during ONS Congress on April 10 in Anaheim, Calif.

LEARN MORE

FFlogo

Inspire the Next Generation of Cancer Immunotherapy Leaders

Advance the science of cancer immunotherapy and help young investigators tackle hurdles facing the field with a gift to the SITC Forward Fund.

Donate Today

sitc_log_color.png


Register Today

Free Meet-the-Expert Webinar on Mar. 8:
How to Survive in Academia

LEARN MORE

sitc_log_color.png


Join a SITC Professional Interest Community

Create new collaborations, build your professional network and discuss the latest research trends in SITC Professional Interest Communities.

Learn More and Join Today

Patient

Explore resources and educational opportunities for cancer patients and those who advocate for them.

Explore

 

 

 

 

Clinician

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.

Explore

 

 

 

 

Researcher

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.

Explore

 

 

 

 

Latest Discussions

  • Hello Anyone can share their experience with sarcoidosis flare after treatment with a PD-1 inhibitor? Thank you ------------------------------ Priscila Goncalves Associate Director Center for Novel Cancer Therapies Northwell Health - Monter Cancer Center ...

  • Posted in: Women in SITC

    Hello ladies Does anyone have experience with sarcoidosis flare after treatment with a checkpoint inhibitor? I know it is possible and has been described, but wondering on the risk/benefit ratio for a patient of mine.  Thanks Priscila ------------------------------ ...

  • Posted in: Women in SITC

    Welcome Susanna! ------------------------------ Priscila Goncalves Associate Director Center for Novel Cancer Therapies Northwell Health - Monter Cancer Center Lake Success, NY ------------------------------

Follow the SITC Twitter Feed.

 

Connect with colleagues at these Upcoming Events.

 


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.

 

Learn More

 

The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

 

Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

 

Learn More